Jiuzhitang Co Ltd
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment: Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong … Read more
Jiuzhitang Co Ltd - Asset Resilience Ratio
Jiuzhitang Co Ltd (000989) has an Asset Resilience Ratio of 12.97% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Jiuzhitang Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Jiuzhitang Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥648.00 Million | 12.97% |
| Total Liquid Assets | CN¥648.00 Million | 12.97% |
Asset Resilience Insights
- Moderate Liquidity: Jiuzhitang Co Ltd has 12.97% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Jiuzhitang Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jiuzhitang Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp Preferred
KO:000105 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma
KO:000220 |
Drug Manufacturers - Specialty & Generic | 1.74% |
|
Ildong Holdings Co Ltd
KO:000230 |
Drug Manufacturers - Specialty & Generic | 1.57% |
Annual Asset Resilience Ratio for Jiuzhitang Co Ltd (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Jiuzhitang Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 5.76% | CN¥300.00 Million | CN¥5.21 Billion | +1.42pp |
| 2023-12-31 | 4.34% | CN¥231.20 Million | CN¥5.33 Billion | -1.60pp |
| 2020-12-31 | 5.94% | CN¥301.39 Million | CN¥5.07 Billion | -5.34pp |
| 2019-12-31 | 11.29% | CN¥553.58 Million | CN¥4.90 Billion | +7.87pp |
| 2018-12-31 | 3.41% | CN¥179.16 Million | CN¥5.25 Billion | +1.71pp |
| 2017-12-31 | 1.70% | CN¥100.00 Million | CN¥5.87 Billion | +1.64pp |
| 2010-12-31 | 0.06% | CN¥1.03 Million | CN¥1.74 Billion | 0.00pp |
| 2009-12-31 | 0.06% | CN¥936.29K | CN¥1.55 Billion | -8.49pp |
| 2008-12-31 | 8.56% | CN¥132.28 Million | CN¥1.55 Billion | +7.85pp |
| 2007-12-31 | 0.70% | CN¥10.10 Million | CN¥1.44 Billion | -0.21pp |
| 2006-12-31 | 0.91% | CN¥12.56 Million | CN¥1.37 Billion | -5.04pp |
| 2005-12-31 | 5.95% | CN¥77.61 Million | CN¥1.30 Billion | +5.39pp |
| 2004-12-31 | 0.57% | CN¥7.61 Million | CN¥1.34 Billion | -0.29pp |
| 2003-12-31 | 0.86% | CN¥11.53 Million | CN¥1.34 Billion | +0.47pp |
| 2002-12-31 | 0.39% | CN¥3.95 Million | CN¥1.02 Billion | -- |